INmune Bio, Inc. (INMB) Misses Q3 EPS by 8c

INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Goldman Sachs closes short THB/INR trade for small gain
• Trump on Iran: they're not going to make the kind of deal that I think is necessary